Intrexon Corp. Company Profile (NYSE:XON)

About Intrexon Corp.

Intrexon Corp. logoIntrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. Its technologies combine the principles of precision engineering, statistical modeling, automation and production at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing, or LEAP, and ActoBiotics platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: XON
  • CUSIP:
Key Metrics:
  • Previous Close: $28.04
  • 50 Day Moving Average: $27.36
  • 200 Day Moving Average: $28.66
  • 52-Week Range: $18.52 - $43.76
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -41.20
  • P/E Growth: 0.49
  • Market Cap: $3.24B
  • Outstanding Shares: 118,325,000
  • Beta: 1.54
Profitability:
  • Net Margins: -96.65%
  • Return on Equity: -19.00%
  • Return on Assets: -13.11%
Debt:
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 3.62%
  • Quick Ratio: 3.36%
Additional Links:
Companies Related to Intrexon Corp.:

Analyst Ratings

Consensus Ratings for Intrexon Corp. (NYSE:XON) (?)
Ratings Breakdown: 2 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $45.17 (66.11% upside)

Analysts' Ratings History for Intrexon Corp. (NYSE:XON)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016Griffin SecuritiesReiterated RatingBuy$55.00View Rating Details
7/17/2016JMP SecuritiesReiterated RatingBuyView Rating Details
7/7/2016WunderlichReiterated RatingBuy$50.00View Rating Details
6/29/2016Stifel NicolausReiterated RatingBuy$57.00View Rating Details
3/3/2016Bank of America Corp.Reiterated RatingNeutral$41.00 -> $38.00View Rating Details
3/1/2016MizuhoReiterated RatingNeutral$28.00 -> $29.00View Rating Details
8/11/2015Merriman CapitalUpgradeNeutral -> Buy$85.00View Rating Details
8/11/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$45.00 -> $55.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Intrexon Corp. (NYSE:XON)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.26)($0.42)$53.78 million$52.50 millionViewN/AView Earnings Details
5/10/2016Q1($0.20)($0.55)$46.26 million$43.40 millionViewListenView Earnings Details
2/29/2016Q415($0.18)($0.28)$41.82 million$41.50 millionViewListenView Earnings Details
11/9/2015Q3($0.21)($0.34)$40.84 million$53.40 millionViewN/AView Earnings Details
8/10/2015Q215($0.04)$0.01$55.93 million$44.90 millionViewListenView Earnings Details
5/11/2015Q115($0.12)$0.25$32.90 million$33.80 millionViewListenView Earnings Details
3/2/2015Q414($0.16)$0.18$26.11 million$31.10 millionViewN/AView Earnings Details
11/13/2014Q314($0.16)($0.53)$19.40 million$21.20 millionViewN/AView Earnings Details
8/14/2014Q214($0.13)($0.11)$9.39 million$11.80 millionViewN/AView Earnings Details
5/7/2014Q1$0.06$0.04$11.25 million$7.90 millionViewN/AView Earnings Details
3/31/2014Q413($0.14)($0.13)$8.38 million$7.10 millionViewN/AView Earnings Details
11/7/2013($0.03)$0.15$9.79 million$6.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intrexon Corp. (NYSE:XON)
Current Year EPS Consensus Estimate: $-1.36 EPS
Next Year EPS Consensus Estimate: $-0.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.22)($0.21)($0.22)
Q2 20162($0.22)($0.21)($0.22)
Q3 20162($0.26)($0.22)($0.24)
Q4 20162($0.27)($0.18)($0.23)
Q1 20171($0.26)($0.26)($0.26)
Q2 20171($0.24)($0.24)($0.24)
Q3 20171($0.26)($0.26)($0.26)
Q4 20171($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intrexon Corp. (NYSE:XON)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intrexon Corp. (NYSE:XON)
Insider Ownership Percentage: 55.10%
Institutional Ownership Percentage: 84.05%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/29/2016Nir NimrodiSVPBuy4,000$26.12$104,480.00View SEC Filing  
5/13/2016Randal J KirkCEOBuy41,830$23.92$1,000,573.60View SEC Filing  
12/11/2015Randal J KirkCEOBuy124,475$29.85$3,715,578.75View SEC Filing  
12/7/2015Randal J KirkCEOBuy237,525$30.69$7,289,642.25View SEC Filing  
12/4/2015Suma KrishnanSVPSell20,900$35.66$745,294.00View SEC Filing  
1/27/2015Randal J KirkCEOBuy555,556$27.00$15,000,012.00View SEC Filing  
5/13/2014Donald LehrInsiderBuy1,850$15.99$29,581.50View SEC Filing  
5/13/2014Randal KirkCEOBuy65,173$15.19$989,977.87View SEC Filing  
5/9/2014Kelly HuangSVPBuy3,200$15.78$50,496.00View SEC Filing  
5/9/2014Krish KrishnanCOOBuy20,900$14.21$296,989.00View SEC Filing  
3/27/2014Randal KirkCEOBuy243,001$25.72$6,249,985.72View SEC Filing  
3/4/2014Gregory Ian FrostSVPBuy100,000$25.95$2,595,000.00View SEC Filing  
8/13/2013Jeffrey B KindlerDirectorBuy33,000$16.00$528,000.00View SEC Filing  
8/13/2013Randal J KirkCEOBuy1,887,500$16.00$30,200,000.00View SEC Filing  
8/13/2013Thomas D ReedInsiderBuy1,800$16.00$28,800.00View SEC Filing  
8/13/2013Thomas R KasserSVPBuy5,000$16.00$80,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Intrexon Corp. (NYSE:XON)
DateHeadline
News IconVolatile Mix Cap Mover- Intrexon Corporation (NYSE:XON), USG Corporation (NYSE:USG), Shire (NASDAQ:SHPG) - Seneca Globe (NYSE:XON)
www.senecaglobe.com - September 26 at 6:46 AM
4-traders.com logoIntrexon : to Develop Disease-Modifying Therapies in New Collaborations with Harvest Intrexon Enterprise Fund (NYSE:XON)
www.4-traders.com - September 25 at 5:43 AM
fidaily.com logoShares Trading unchanged at $28.04 (XON) Intrexon to Develop ... - Finance Daily (NYSE:XON)
www.fidaily.com - September 24 at 5:34 AM
streetinsider.com logoIntrexon (XON) Enters into Exclusive Channel Collaborations with Two Startups - StreetInsider.com (NYSE:XON)
www.streetinsider.com - September 23 at 7:33 PM
News IconIntrexon Corp Price Target Lowered to $50.00 at Wunderlich (XON) - Petro Global News 24 (NYSE:XON)
petroglobalnews24.com - September 23 at 7:33 PM
publicnow.com logoIntrexon to Develop Disease-Modifying Therapies in New Collaborations with Harvest Intrexon Enterprise Fund (NYSE:XON)
www.publicnow.com - September 23 at 7:33 PM
News IconBiotech stocks for your portfolio: Intrexon Corporation (XON), Sarepta Therapeutics, Inc. (SRPT) - The Independent Republic (NYSE:XON)
theindependentrepublic.com - September 22 at 7:49 PM
News IconIntrexon Corp Now Covered by Analysts at Bank of America (XON) - Petro Global News 24 (NYSE:XON)
petroglobalnews24.com - September 22 at 7:49 PM
News IconIntrexon Corp's (XON) “Buy” Rating Reiterated at Griffin Securities ... - DailyQuint (NYSE:XON)
dailyquint.com - September 21 at 7:42 PM
News IconBiotech news that matter for investors: Intrexon Corporation (NYSE ... - The Voice Registrar (NYSE:XON)
voiceregistrar.com - September 21 at 7:42 PM
News IconBiotech Stocks To Put On Your Watch List: Intrexon Corporation (NYSE:XON), Idera Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar (NYSE:XON)
voiceregistrar.com - September 19 at 3:16 PM
fool.com logoThe Race to Cure the Zika Virus is On, and This Company May Have the Best Solution (NYSE:XON)
www.fool.com - September 19 at 3:16 PM
investopedia.com logoIntrexon's Mosquitoes to Hit Zika at Source (XON) - Investopedia (NYSE:XON)
www.investopedia.com - September 15 at 8:20 PM
investopedia.com logoBiotherapeutics: A Long-Run Bet by Intrexon (XON) - Investopedia (NYSE:XON)
www.investopedia.com - September 15 at 8:20 PM
investopedia.com logoIntrexon’s Mosquitoes to Hit Zika at Source (XON) (NYSE:XON)
www.investopedia.com - September 15 at 8:20 PM
investopedia.com logoBiotherapeutics: A Long-Run Bet by Intrexon (XON) (NYSE:XON)
www.investopedia.com - September 15 at 8:20 PM
cnbc.com logoCramer: I'm shocked by the momentum for this Chinese stock (NYSE:XON)
www.cnbc.com - September 15 at 12:00 PM
finance.yahoo.com logoExemplar Genetics ExeGen® Cystic Fibrosis Research Model Utilized in Development of New Gene Therapy Treatments (NYSE:XON)
finance.yahoo.com - September 14 at 12:36 PM
News IconAnalysts Valuations For Two Stocks: Intrexon Corp (NYSE:XON), Patterson Companies, Inc. (NASDAQ:PDCO) - The Voice Registrar (NYSE:XON)
voiceregistrar.com - September 13 at 5:46 AM
News IconNotable Stocks In Focus: Intrexon Corp (NYSE:XON), Valeant ... - NYSE Journal (press release) (NYSE:XON)
stockznews.com - September 8 at 7:48 PM
News IconShares of Seagate Technology PLC (NASDAQ:STX) & Intrexon Corp (NYSE:XON) Stocks News Update: Wednesday - Money News (NYSE:XON)
www.newsismoney.com - September 8 at 7:48 PM
reuters.com logoFlorida politicians urge use of Intrexon GM mosquitoes for Zika - Reuters (NYSE:XON)
www.reuters.com - September 8 at 7:48 PM
thestreet.com logoIntrexon (XON) Stock Up, JMP Securities: Mosquito Authorization Could Boost Revenue (NYSE:XON)
www.thestreet.com - September 8 at 7:48 PM
stockhouse.com logoFibrocell Announces Closing of $18 Million Private Placement (NYSE:XON)
www.stockhouse.com - September 8 at 12:08 PM
capitalcube.com logoIntrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : September 8, 2016 (NYSE:XON)
www.capitalcube.com - September 8 at 12:08 PM
reuters.com logoOklahoma Sept. 3 earthquake was strongest recorded in state -USGS (NYSE:XON)
www.reuters.com - September 7 at 8:18 PM
finance.yahoo.com logo1:23 pm Intrexon reports a bipartisan coalition of 61 Florida House members issued a letter urging the U.S. Federal Government to take steps including Emergency Use Authorization to allow Florida's state/local governments to use Oxitec's ge (NYSE:XON)
finance.yahoo.com - September 7 at 8:18 PM
publicnow.com logoFlorida Speaker-Designate and House Members Request Emergency Authorization to Combat Aedes aegypti Mosquitoes with Oxitec Technology (NYSE:XON)
www.publicnow.com - September 7 at 8:18 PM
finance.yahoo.com logoFlorida politicians urge use of Intrexon GM mosquitoes for Zika (NYSE:XON)
finance.yahoo.com - September 7 at 8:18 PM
thestreet.com logoHere's a Reason Why Intrexon (XON) Stock Is Gaining Today (NYSE:XON)
www.thestreet.com - September 7 at 8:18 PM
marketwired.com logoSapience Therapeutics Adds Former Head of the National Cancer Institute, Samuel Broder, MD, to Board of Directors (NYSE:XON)
www.marketwired.com - September 7 at 12:06 PM
News IconFloridians Oppose FDA-approved Genetically Modified Mosquitoes (NYSE:XON)
www.thenewamerican.com - September 6 at 8:19 PM
finance.yahoo.com logoOxitec and Piracicaba City Hall Start Release of Friendly™ Aedes (NYSE:XON)
finance.yahoo.com - September 6 at 8:18 PM
publicnow.com logoOxitec and Piracicaba City Hall Start Release of Friendly™ Aedes in Additional 10 Downtown Neighborhoods (NYSE:XON)
www.publicnow.com - September 6 at 8:18 PM
fool.com logoIntrexon Investors Are Neglecting This Technology Platform (NYSE:XON)
www.fool.com - September 6 at 8:18 PM
streetinsider.com logoForm 4 ZIOPHARM ONCOLOGY INC For: Aug 31 Filed by: KIRK RANDAL J (NYSE:XON)
www.streetinsider.com - September 2 at 8:00 PM
prnewswire.com logoPurcell Julie & Lefkowitz LLP Is Investigating Intrexon Corporation ... - PR Newswire (press release) (NYSE:XON)
www.prnewswire.com - September 2 at 6:38 AM
prnewswire.com logoPurcell Julie & Lefkowitz LLP Is Investigating Intrexon Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NYSE:XON)
www.prnewswire.com - September 1 at 8:10 PM
benzinga.com logoXON: Insiders vs. Shorts (NYSE:XON)
www.benzinga.com - September 1 at 11:34 AM
News IconPurcell Julie & Lefkowitz LLP Is Investigating Intrexon Corporation for Potential Breaches Of Fiduciary Duty By Its Board of ... (NYSE:XON)
ih.advfn.com - September 1 at 11:34 AM
News IconOxitec’s U.S. owner forms PAC to promote GMO mosquitoes before vote taken in Keys (NYSE:XON)
www.miamiherald.com - August 31 at 5:48 AM
fool.com logoZiopharm Has a Data Problem (NYSE:XON)
www.fool.com - August 30 at 8:04 PM
News IconPublic comments so far show support for 3rd GMO apple (NYSE:XON)
www.foodsafetynews.com - August 26 at 11:14 AM
capitalcube.com logoIntrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : August 26, 2016 (NYSE:XON)
www.capitalcube.com - August 26 at 11:14 AM
capitalcube.com logoETF’s with exposure to Intrexon Corp. : August 26, 2016 (NYSE:XON)
www.capitalcube.com - August 26 at 11:14 AM
News IconMatthew Crisp – President and CEO of Benson Hill Biosystems (NYSE:XON)
ideamensch.com - August 25 at 5:43 AM
publicnow.com logoOragenics Selects New Lantibiotic for Further Development in Clostridium difficile Infections (NYSE:XON)
www.publicnow.com - August 23 at 10:47 AM
bizjournals.com logoFlorida controversy stops genetically modified mosquitoes from fighting Zika in the U.S. (NYSE:XON)
www.bizjournals.com - August 20 at 7:51 PM
bizjournals.com logoThe controversy that’s stopping genetically modified mosquitoes from fighting Zika in the U.S. (NYSE:XON)
www.bizjournals.com - August 19 at 11:21 AM
fool.com logoWhat Zika Virus in Florida Means (and Doesn't Mean) for Intrexon (NYSE:XON)
www.fool.com - August 19 at 11:21 AM

Social

Intrexon Corp. (NYSE:XON) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff